http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004016741-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3864b52216b1b77c6140f797a1f17532
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
filingDate 2003-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ee252555280078794fef34d2f37392a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_834c601d8955037cdf0abdc35698eaac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d055178b7f9e271cbb1114ec53fa888
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60360cd7269166ecc27f20e65fe647fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c395ca0be848209bbf3d1bbd0896a58b
publicationDate 2004-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2004016741-A3
titleOfInvention Prenylation inhibitors containing dimethyl-cyclobutane and methods of their synthesis and use
abstract The present invention is directed to compounds useful in the treatment of diseases associated with prenylation of proteins and pharmaceutically acceptable salts thereof, to pharmaceutical compositions comprising same, and to methods for inhibiting protein prenylation in an organism using the same.
priorityDate 2002-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6664277-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5631401-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410517909
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID638049

Total number of triples: 35.